Dennis Slamon

Dennis Slamon is an American oncologist and a prominent figure in the field of cancer research. He is best known for his work in the development of Herceptin, a groundbreaking drug for the treatment of breast cancer.

Early Life and Education[edit | edit source]

Dennis Slamon was born in the United States. He completed his undergraduate studies at the University of Chicago, where he developed an interest in biology and medicine. He later attended the University of Chicago Pritzker School of Medicine, where he earned his medical degree.

Career[edit | edit source]

After completing his medical degree, Slamon pursued a career in oncology, specializing in the research and treatment of cancer. He joined the faculty of the University of California, Los Angeles (UCLA), where he currently serves as a Professor of Medicine.

Slamon's most significant contribution to the field of oncology is his work on the development of Herceptin, a drug used in the treatment of breast cancer. His research focused on the HER2/neu gene, which is overexpressed in some forms of breast cancer. Slamon's work led to the development of Herceptin, which specifically targets cells overexpressing the HER2/neu gene.

Recognition[edit | edit source]

Slamon's work has earned him numerous awards and recognitions, including the Lasker Award for Clinical Medical Research and the Gairdner Foundation International Award. His work has also been recognized by the American Cancer Society and the National Cancer Institute.